TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

SHTDY

SINOPHARM GROUP CO LTD ADR

PINKCommon Stock
$10.50
+1.94%today

No SEC filings for this security

SINOPHARM GROUP CO LTD ADR is a foreign or OTC-listed security (PINK) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$9.89 – $13.32
9.8952-week13.32
Market cap
$6.57B
Volume
325.00
1Y return
-11.14%
Beta
0.44

Price · 1Y

$10.50▼ -11.14%
over 1Y
L $9.94H $14.07

Recent news

market news →
Sinopharm Explores Noninvasive Glucose Monitoring To Deepen China Diabetes RoleBullish
finance.yahoo.com· 2026-03-21
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter TrialsBullish
finance.yahoo.com· 2026-03-19
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial OpportunitiesBullish
finance.yahoo.com· 2026-03-19
3 Compelling Dividend Stocks Offering Yields Up To 5.1%Bullish
finance.yahoo.com· 2025-01-28
Top 3 Dividend Stocks To Enhance Your PortfolioBullish
finance.yahoo.com· 2024-12-12
3 Dividend Stocks Yielding Up To 4.5%Bullish
finance.yahoo.com· 2024-11-08
Sinopharm Group And 2 More SEHK Dividend Stocks To Boost Your PortfolioBullish
finance.yahoo.com· 2024-10-02
Top SEHK Dividend Stocks To Consider In September 2024Bullish
finance.yahoo.com· 2024-09-16

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.